cancer immunotherapy
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
cancer immunotherapy
Jul 20, 2024, 16:39 |
Blog
Submit your abstract for CICON24 - European Network for Cancer Immunotherapy
European Network for Cancer Immunotherapy shared a post on LinkedIn: “CICON24 has added a second…
Jul 14, 2024, 05:05 |
Blog
Wurzburg University is searching for a PhD student interested in developing novel CRISPR 2.0 gene editing
Karl Petri, Emmy Noether group leader at University Hospital Wuerzburg, shared a post on X/Twitter: ''We…
Jul 11, 2024, 04:24 |
Blog
Justin Eyquem Named a 2024 Pew-Stewart Scholar for Cancer Research
Parker Institute for Cancer Immunotherapy made the following post on X: "Congratulations to PICI Investigator Justin…
Jul 6, 2024, 08:14 |
Insight
Aline Pfefferle: Our pan-cancer human NK cell atlas
Karl-Johan Malmberg, Director, Center of Excellence: Precision Immunotherapy Alliance (PRIMA) at The University of Oslo,…
Jul 2, 2024, 02:01 |
Blog
SCION 2025 equips participants with insights into cancer immunotherapy clinical trials - SITC
SITC (Society for Immunotherapy of Cancer) Early Career Scientist Committee shared on X: …
Jul 1, 2024, 15:04 |
Blog
2024 class of Early Career Researcher recipients - Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy made the following post on X: "PICI is thrilled to award…
Jun 25, 2024, 12:32 |
Blog
Jedd Wolchok shares his expert insights in cancer immunotherapy
Cancer Research Institute shared a post on LinkedIn: “What is immunotherapy, and how does it work?…
Jun 21, 2024, 18:05 |
Blog
Nature Reviews Cancer - Exploiting temporal aspects of cancer immunotherapy
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital,…
Jun 17, 2024, 00:44 |
Blog
Significant milestone at our START Madrid FJD location! - The START Center for Cancer Research
The START Center for Cancer Research shared on LinkedIn: “We're thrilled to announce a significant milestone…
Jun 15, 2024, 01:18 |
Blog
Karen Knudsen: All in against cancer with my friends from Coaches vs. Cancer
Karen Knudsen shared on LinkedIn: “All in against cancer with my friends from Coaches vs. Cancer…
Jun 14, 2024, 13:28 |
Insight
June is Cancer Immunotherapy Awareness Month - NCI-Designated Cancer Center at Sanford Burnham Prebys
NCI-Designated Cancer Center at Sanford Burnham Prebys shared on LinkedIn: “June is also Cancer Immunotherapy…
Jun 14, 2024, 01:04 |
Blog
Oscar Felipe Borja: Had the opportunity to present at the Cancer Immunotherapy conference by Nature Portfolio
Oscar Felipe Borja, Resident Physician at the University of New Mexico School of Medicine, recently…
Jun 10, 2024, 06:14 |
Blog
Myriam Chalabi: Happy moment with Christian Blank
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, shared a post…
Jun 8, 2024, 06:59 |
Blog
Results of the NICHE-2 trial show it to be highly effective in a subset of patients with colon cancer - The Netherlands Cancer Institute
The Netherlands Cancer Institute shared on Linkedin: “More succes for neoadjuvant immunotherapy: results of the…
Jun 7, 2024, 08:54 |
Insight
Andrew Allen: What an exciting time to be in the field of personalized cancer vaccines
Andrew Allen, President, CEO and Co-Founder at Gritstone Bio, recently shared on LinkedIn: "Cancer immunotherapy…
May 30, 2024, 12:55 |
Immune Oncology
History of Immunotherapy: Cancer Treatment
Immunotherapy Immunotherapy is a revolutionary approach to cancer treatment that harnesses the power of the…
May 29, 2024, 13:43 |
Immune Oncology
Immunotherapy for Cancer: An Overview
What is immunotherapy? Immunotherapy is a type of cancer treatment that uses the body's immune…
May 25, 2024, 14:20 |
Blog
Marc Machaalani: Immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC
Marc Machaalani, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post by ASCO on…
May 23, 2024, 11:18 |
Blog
Sarabjot Pabla: Our latest molecular tumor board with a case of recurrent HCC
Sarabjot Pabla, Head of Clinical and Research Bioinformatics at OmniSeq, shared a post on LinkedIn:…
May 22, 2024, 08:48 |
Blog
SITC will host the free Summit on Immunomodulation of ADCs
Society for Immunotherapy of Cancer shared a post on X: “SITC will host the free Summit…
May 15, 2024, 15:06 |
Blog
Submit an abstract for CICON24 - Cancer Research Institute
Cancer Research Institute (CRI) shared on LinkedIn: "CICON24 promises to be an unmissable event for anyone…
May 11, 2024, 01:27 |
Blog
Abhishek Garg: Circadian rhythm based regulation of CD8+T cell function dictates the efficacy of cancer immunotherapy
Abhishek Garg, Head of Laboratory of Cell Stress and Immunity (CSI) Lab at KU Leuven,…
May 10, 2024, 08:10 |
Insight
The intricate world of copper-dependent pathways within tumor cells - The Babak Lab
Maria Babak, Assistant Professor at City University of Hong Kong, shared a post by The Babak…
May 2, 2024, 12:56 |
Blog
Susanna F. Greer: An unexpected GOOD sign - tumor associated macrophages and breast cancer
Susanna F. Greer, Chief Scientific Officer at the V Foundation, published the following newsletter on…
May 1, 2024, 21:39 |
Blog
It’s the one-two punch cancer treatment that ‘floats like a butterfly, and STINGs like a bee’! - WEHI (Walter and Eliza Hall Institute of Medical Research)
WEHI (Walter and Eliza Hall Institute of Medical Research) made the foll0wing post on LinkedIn:…
May 1, 2024, 19:24 |
Blog
SIOP Women Leaders in Paediatric Oncology Network celebrates Dr. Crystal Mackall
SIOP Women Leaders in Paediatric Oncology Network shared on X/Twitter: “We celebrate women leaders in…
Apr 28, 2024, 23:40 |
Blog
Susanna Greer: Boosting the CAR T party
Susanna Greer, Chief Scientific Officer at the V Foundation for Cancer Research, published the following…
Apr 27, 2024, 12:57 |
Blog
Matteo Morotti: The results of our study on the effect of prostaglandin E2 on T cells
Matteo Morotti, Medical program leader at CDR-Life, shared on X/Twitter: "Proud to share the results…
Apr 25, 2024, 12:10 |
Blog
Myriam Chalabi: Very happy to host Ulrike Harjes from Nature Medicine
Myriam Chalabi: Medical Oncologist and Cancer Immunotherapy Researcher at Antoni van Leeuwenhoek, The Netherlands Cancer…
Apr 23, 2024, 23:05 |
Opinion
Have you submitted your abstract for International Cancer Immunotherapy Conference? - CRI
Cancer Research Institute (CRI) shared a following post on LinkedIn: "Have you submitted your abstract…
Apr 18, 2024, 19:48 |
Blog
Join Dana-Farber Cancer Institute in Boston on June 10-12 for Cancer Immunotherapy: From Bench to Bedside and Back
Dana-Farber Cancer Institute shared a post on LinkedIn: "Join us in Boston on June 10-12 for…
Apr 17, 2024, 00:52 |
Insight
UHN Research - Can a blood sample be used to predict patient outcomes to cancer immunotherapy drug pembrolizumab?
UHN Research shared on their LinkedIn: "Can a blood sample be used to predict patient…
Apr 16, 2024, 13:31 |
Blog
Sarabjot Pabla: What an incredible opportunity it was to be part of AACR2024
Sarabjot Pabla, Head of Clinical and Research Bioinformatics at OmniSeq, shared on their LinkedIn: ''What…
Apr 14, 2024, 10:26 |
Insight
Iván González: A comprehensive review of immune system adverse events due to cancer immunotherapy
Iván González, Medical Oncologist at Comprehensive Oncology Center of the Hospital Ángeles Puebla, shared on…
Mar 31, 2024, 08:18 |
Drugs
Jeffrey Martin: Bispecific antibodies - what are they and who's making them?
Jeffrey Martin, Founder of Oncoleader, recently shared on LinkedIn: "Bispecific antibodies: what are they and…
Mar 21, 2024, 16:52 |
Blog
Georgina Long: I’m honored to give a talk at Keystone Symposia on "Cancer Immunotherapy: Beyond Immune Checkpoint Blockade and Overcoming Resistance"
Georgina Long, recently posted on X: "Heading to the Keystone Symposia on ‘Cancer Immunotherapy: Beyond…
Mar 1, 2024, 17:25 |
Insight
Marco Donia: The 'Influencers' of Cancer Immunotherapy do not affect immunotherapy outcomes
Marco Donia, Associate Professor at National Center for Cancer Immune Therapy, Denmark, shared on LinkedIn: "The…
Mar 1, 2024, 16:32 |
Blog
Yardena Samuels discusses how ongoing research is revisiting the classic neoantigen approach - The European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) posted on LinkedIn: “ESMOTAT24: Novel antigens for cancer…
Jan 16, 2024, 11:33 |
Blog
Patrick Hwu: Mario Sznol is one of the most thoughtful translational cancer immunotherapists I know
Patrick Hwu, President and CEO at Moffitt Cancer Center, shared on X/Twitter: "So good to…
Jan 6, 2024, 16:54 |
Career
Randy Sweis: Fully funded postdoctoral scholar positions are now open in our lab in Chicago
Quoting Randy Sweis, Physician-Scientist in Cancer Immunotherapy at University of Chicago, on X/Twitter: ''Fully funded…
Dec 18, 2023, 21:17 |
Insight
Anthony Zamora: How advancements in sequencing technologies and bioinformatics pipelines have advanced our ability to identify cancer neoantigens
Anthony Zamora, Assistant Professor at the Medical College of Wisconsin, announced on LinkedIn: "Happy to…
Dec 8, 2023, 17:50 |
Drugs
Pure Biologics to test molecule PBA-0405 in project PB004 in a Phase 0 clinical trial in patients with solid tumors - The Antibody Society
The Antibody Society shared on their LinkedIn page: "In an unusual (to us anyway) move,…
Nov 13, 2023, 07:41 |
Blog
The Cancer Research Institute's 2023 Annual Awards Dinner
Cancer Research Institute shared on their LinkedIn page: ''The Cancer Research Institute's 2023 Annual Awards…
Oct 26, 2023, 22:57 |
Opinion
Leonidas Platanias: Steven Rosenberg deserves the Nobel Prize for his incredible work in cancer immunotherapy
Leonidas Platanias, Director of the Lurie Comprehensive Cancer Center of Northwestern University, shared the following post…
All:
44
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube